Literature DB >> 27496553

Carbogen-induced increases in tumor oxygenation depend on the vascular status of the tumor: A multiparametric MRI study in two rat glioblastoma models.

Ararat Chakhoyan1,2,3,4, Aurélien Corroyer-Dulmont1,2,3,4, Marine M Leblond1,2,3,4, Aurélie Gérault1,2,3,4, Jérôme Toutain1,2,3,4, Laurent Chazaviel1,2,3,4,5, Didier Divoux1,2,3,4, Edwige Petit1,2,3,4, Eric T MacKenzie1,2,3,4, François Kauffmann4,6, Nicolas Delcroix3,5, Myriam Bernaudin1,2,3,4, Omar Touzani1,2,3,4, Samuel Valable1,2,3,4.   

Abstract

The alleviation of hypoxia in glioblastoma with carbogen to improve treatment has met with limited success. Our hypothesis is that the eventual benefits of carbogen depend on the capacity for vasodilation. We examined, with MRI, changes in fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent signals in response to carbogen. The analyses were performed in two xenograft models of glioma (U87 and U251) recognized to have different vascular patterns. Carbogen increased fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent signals in contralateral tissues. In the tumor core and peritumoral regions, changes were dependent on the capacity to vasodilate rather than on resting fractional cerebral blood volume. In the highly vascularised U87 tumor, carbogen induced a greater increase in fractional cerebral blood volume and blood oxygen saturation in comparison to the less vascularized U251 tumor. The blood oxygenation level dependent signal revealed a delayed response in U251 tumors relative to the contralateral tissue. Additionally, we highlight the considerable heterogeneity of fractional cerebral blood volume, blood oxygen saturation, and blood oxygenation level dependent within U251 tumor in which multiple compartments co-exist (tumor core, rim and peritumoral regions). Finally, our study underlines the complexity of the flow/metabolism interactions in different models of glioblastoma. These irregularities should be taken into account in order to palliate intratumoral hypoxia in clinical trials.

Entities:  

Keywords:  Dynamic blood oxygenation level dependent; fractional cerebral blood volume; glioma; hypoxia; tissue oxygen saturation

Mesh:

Substances:

Year:  2016        PMID: 27496553      PMCID: PMC5464716          DOI: 10.1177/0271678X16663947

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  34 in total

1.  Dynamic changes in oxygenation of intracranial tumor and contralateral brain during tumor growth and carbogen breathing: a multisite EPR oximetry with implantable resonators.

Authors:  Huagang Hou; Ruhong Dong; Hongbin Li; Benjamin Williams; Jean P Lariviere; S K Hekmatyar; Risto A Kauppinen; Nadeem Khan; Harold Swartz
Journal:  J Magn Reson       Date:  2011-10-01       Impact factor: 2.229

2.  Arsenic trioxide treatment decreases the oxygen consumption rate of tumor cells and radiosensitizes solid tumors.

Authors:  Caroline Diepart; Oussama Karroum; Julie Magat; Olivier Feron; Julien Verrax; Pedro Buc Calderon; Vincent Grégoire; Philippe Leveque; Julie Stockis; Nicolas Dauguet; Bénédicte F Jordan; Bernard Gallez
Journal:  Cancer Res       Date:  2011-12-02       Impact factor: 12.701

3.  Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.

Authors:  Benjamin Lemasson; Thomas Christen; Raphaël Serduc; Cécile Maisin; Audrey Bouchet; Géraldine Le Duc; Chantal Rémy; Emmanuel L Barbier
Journal:  Radiology       Date:  2012-09-20       Impact factor: 11.105

4.  Complementary information from magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography in the assessment of the response to an antiangiogenic treatment in a rat brain tumor model.

Authors:  Samuel Valable; Edwige Petit; Simon Roussel; Léna Marteau; Jérôme Toutain; Didier Divoux; Franck Sobrio; Jérôme Delamare; Louisa Barré; Myriam Bernaudin
Journal:  Nucl Med Biol       Date:  2011-04-21       Impact factor: 2.408

5.  Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing.

Authors:  M R Horsman; D W Siemann; D J Chaplin; J Overgaard
Journal:  Radiother Oncol       Date:  1997-11       Impact factor: 6.280

6.  Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.

Authors:  Aurélien Corroyer-Dulmont; Elodie A Pérès; Edwige Petit; Lucile Durand; Léna Marteau; Jérôme Toutain; Didier Divoux; Simon Roussel; Eric T MacKenzie; Louisa Barré; Myriam Bernaudin; Samuel Valable
Journal:  Biol Chem       Date:  2013-04       Impact factor: 3.915

7.  Short communication: the addition of carbogen and nicotinamide to a palliative fractionation schedule for locally advanced breast cancer.

Authors:  K Pigott; S Dische; M I Saunders
Journal:  Br J Radiol       Date:  1995-02       Impact factor: 3.039

Review 8.  Advances in Intracranial Pressure Monitoring and Its Significance in Managing Traumatic Brain Injury.

Authors:  Usmah Kawoos; Richard M McCarron; Charles R Auker; Mikulas Chavko
Journal:  Int J Mol Sci       Date:  2015-12-04       Impact factor: 5.923

9.  Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Authors:  Elodie A Pérès; Aurélie N Gérault; Samuel Valable; Simon Roussel; Jérôme Toutain; Didier Divoux; Jean-Sébastien Guillamo; Marc Sanson; Myriam Bernaudin; Edwige Petit
Journal:  Oncotarget       Date:  2015-02-10

Review 10.  Imaging Modalities to Assess Oxygen Status in Glioblastoma.

Authors:  Aurélien Corroyer-Dulmont; Ararat Chakhoyan; Solène Collet; Lucile Durand; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Omar Touzani; Samuel Valable
Journal:  Front Med (Lausanne)       Date:  2015-08-19
View more
  4 in total

1.  The Extension of the LeiCNS-PK3.0 Model in Combination with the "Handshake" Approach to Understand Brain Tumor Pathophysiology.

Authors:  Makoto Hirasawa; Mohammed A A Saleh; Elizabeth C M de Lange
Journal:  Pharm Res       Date:  2022-03-07       Impact factor: 4.580

2.  Hemodynamic and metabolic changes during hypercapnia with normoxia and hyperoxia using pCASL and TRUST MRI in healthy adults.

Authors:  Pieter T Deckers; Alex A Bhogal; Mathijs Bj Dijsselhof; Carlos C Faraco; Peiying Liu; Hanzhang Lu; Manus J Donahue; Jeroen Cw Siero
Journal:  J Cereb Blood Flow Metab       Date:  2021-12-01       Impact factor: 6.960

3.  Prolonged Hyperoxygenation Treatment Improves Vein Graft Patency and Decreases Macrophage Content in Atherosclerotic Lesions in ApoE3*Leiden Mice.

Authors:  Laura Parma; Hendrika A B Peters; Fabiana Baganha; Judith C Sluimer; Margreet R de Vries; Paul H A Quax
Journal:  Cells       Date:  2020-02-01       Impact factor: 6.600

4.  Multimodal evaluation of hypoxia in brain metastases of lung cancer and interest of hypoxia image-guided radiotherapy.

Authors:  Samuel Valable; Jade Fantin; Aurélien Corroyer-Dulmont; Laurent Chatre; Jérôme Toutain; Sylvain Teulier; Céline Bazille; Elise Letissier; Jérôme Levallet; Didier Divoux; Méziane Ibazizène; Stéphane Guillouet; Cécile Perrio; Louisa Barré; Sébastien Serres; Nicola R Sibson; Françoise Chapon; Guénaëlle Levallet; Myriam Bernaudin
Journal:  Sci Rep       Date:  2021-05-27       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.